BETATINIB
Therapeutic Class: Anti-Neoplastic
BTK inhibitor used in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma in appropriate patients. It inhibits B-cell receptor signaling.
As prescribed by Physician
100mg tablet
20–25°C, excursions permitted 15–30°C
